News | Dr. Zubair Khalid
Comprehensive guides and evidence-based reference resources for news.
- A Year After Big Pharma’s UK Pull-Back, Stance Still Unclear
- AbbVie Reports Positive Phase 3 Data for Bispecific T‑Cell Engager in Multiple Myeloma
- AbbVie-Backed ADARx Plans IPO to Fund siRNA Clinical Trials
- Absci CEO Aims to Build Biotech’s Answer to Apple Amid GLP-1 Drug Boom
- ADN Programs
- AlphaFold Database Adds Viral Protein Complexes: NVIDIA, EMBL-EBI and Glasgow
- AlphaGenome Explained: Google DeepMind DNA Model and 9-Billion-Variant Atlas
- American Cancer Society Updates Prostate Cancer Screening Guideline for First Time in 16 Years
- Aminos Research: Amino Acids Beyond Nutrition
- AriBio’s Oral Alzheimer’s Drug Meets Monotherapy Goal in Phase 3; Fosun Considers Licensing
- AstraZeneca Acquires Omniose to Strengthen Bacterial Vaccine Technology
- AstraZeneca Offers $10 Billion to Acquire Rhythm Pharmaceuticals; Analysts Predict Bidding War
- AstraZeneca Pays $200M Upfront for Ex-China Rights to Late-Phase COPD Drug Challenger
- AusperBio Raises $120M Series C for Hepatitis B Oligonucleotide Therapy
- AusperBio Raises $120M, Abcuro Secures $66M in Latest Biotech Fundraising Round
- Axiom Biosciences pursues unconventional route to build biotech company
- Beckman Coulter Receives CE Mark for Alzheimer’s p-Tau217 Assay
- BioCryst Ends Internal Programs; Biogen Cuts Apellis R&D Roles
- Biogen and TrimTech Partner on $411M Protein Degrader Deal for Neurodegenerative Diseases
- Biogen’s Tau-Targeting Therapy Shows Greater Slowing of Alzheimer’s Decline After Two Years
- Biology Degree Careers: Research, Biotech, and More
- Biology in Spanish: Career Benefits for Scientists
- Biology Major Jobs in Healthcare, Biotech, and More
- Biology Research Jobs Across Academia and Industry
- Biomedical Research Advances in Gene Editing and AI
- BioNTech and Genentech Personalized Cancer Vaccine Shows Worse Survival in Terminated Phase 2 Trial
- BioNTech Pays $205 Million for FDA Priority Review Voucher to Accelerate Late-Stage Oncology Drug Filing
- Biospine Institute Launches Stem Cell Trial for Disc Disease
- Biostatistician Jobs
- Biotech Companies
- Biotech ETF
- Biotech Jobs
- Biotech News
- Biotech News Today: CRISPR, AI Drug Discovery and More
- Biotech Revenue Projections Clouded by Medicaid Enrollment Losses from Trump-Era Tax Law
- Biotech Sales
- Biotech Startups
- biotech vc
- Biotechnology Research
- Biotics Research
- BlossomHill Therapeutics and Latigo Biotherapeutics Exceed IPO Expectations
- Boehringer Ingelheim Halts Phase 1 Trial After Safety Event
- Boston Biotech
- Bristol Myers Research Chief Departs as Company Restructures R&D
- BrYet Develops Approach Targeting Cancer-Specific Phenotypes to Outpace Tumor Evolution
- CAAHEP Accredited Sonography Programs
- Careers at UW Medicine: Jobs and How to Apply
- Cell and Molecular Biology Careers and Skills
- Cell Research
- Cellectis to Cut 70% of Workforce in Shift to In Vivo Therapies
- CEPI Commits $16.5 Million to Move Egyptian Biotech’s Ebola Vaccine Into Clinical Trials
- CG Oncology Reports Phase 3 Win for Bladder Cancer Immunotherapy, Plans Expanded FDA Discussions
- Chai Discovery partners with Bristol Myers Squibb for AI antibody discovery
- Chinese Biotech Executives Aim for Big Pharma Status Within a Decade
- Claude Discovers a CRISPR-Like Enzyme System in Phage DNA: The History and Future of Computational Discovery in Biology
- Clinical Research Associate Jobs: Skills and Salary
- Clinical Research Jobs: Roles, Skills and Trends
- Conservation Biology Jobs: Careers and Skills
- Define Tissue Biology
- Delix Therapeutics Raises $100M for Non-Hallucinatory Psychedelic Depression Therapy
- Diagnostic Medical Sonography Programs
- Differentiation Biology
- Differentiation Biology Definition
- Eli Lilly Licenses Amplitude’s RNA Platform for Infectious Disease Vaccines
- Encoded Therapeutics Raises $275 Million to Advance Dravet Syndrome Drug and Expand Manufacturing
- Ensoma Lays Off More Staff, Pauses Preclinical Programs to Focus on Lead Gene Therapy
- Evaxion Halts Infectious Disease and Autoimmune Work to Focus on Cancer Vaccines
- Exela Pharma Sciences
- FAA Medical Certificate: Classes and Requirements
- FDA Appears to Pause Controversial Speedy Review Program and Complete Response Letter Disclosures
- FDA Clears First Standalone Robotic Blood Draw Device
- FDA Extends Review of Capricor’s Duchenne Muscular Dystrophy Cell Therapy
- FDA Grants Accelerated Approval to AstraZeneca’s Camizestrant for ctDNA-Guided Breast Cancer Treatment
- FDA Halts Release of New Drug Rejection Letters, Will Formalize Policy
- FDA Places Clinical Hold on Biohaven Epilepsy Drug After Rodent Study Findings
- FDA Rejects Lung Cancer Drug Ivonescimab From Summit Therapeutics
- FDA Rejects Summit Therapeutics’ Ivonescimab, Blocking US Launch of PD-1xVEGF Drug Class
- Fields of Biology
- Fierce Biotech Competition Reshapes the Industry
- Flagship AI Drug Discovery Biotechs Valo and Montai Merge
- Four Frontiers Shaping Biological Research Today
- Frederick National Laboratory for Cancer Research
- Gate Bioscience Advances Molecular Gate Technology to Eliminate Disease-Causing Proteins
- Genentech Pays $45M Upfront for DualityBio ADCs Targeting Resistant Cancers
- Generate Biomedicines Uses Anthropic’s Claude to Shrink CAR-T Cell Engines
- Genomics Institute of Novartis Research Foundation
- GenScript Biotech Corporation
- GSK Ends $2.2 Billion Alzheimer’s Collaboration with Alector After Two Clinical Failures
- GSK Pays $110M Upfront in Deal Worth Up to $1.3B for Hutchmed Cancer Drug
- Healthcare Certificate Programs for Faster Careers
- Helus Pharma’s Modified Psilocybin Achieves Phase 3 Trial Goals in Major Depression
- How to Choose Ultrasound Tech Programs
- How to Find Biology Jobs Near You
- How to Use RFdiffusion3: Install, Run and Filter All-Atom Designs
- HudsonAlpha Institute for Biotechnology
- Indiana Biosciences Research Institute
- Inhibrx CEO Says OX40 Agonist Shows Durable Progression-Free Survival in Head and Neck Cancer Trial
- Inside the Allergy Research Group's Molecular Work
- Inside the Metabolic Research Center: From Lab to Clinic
- Inside the Novartis Institutes for Biomedical Research
- Inside the Smilow Center for Translational Research
- Institute for Integrative Nutrition
- Invivyd Chairman Marc Elia Appointed CEO Ahead of COVID-19 Data Readout
- Ionis Wins FDA Approval for Alexander Disease Drug, Bolstering Rare Disease Pipeline
- Isomorphic Labs Adds Merck as AI Drug Discovery Partner Days After $5 Billion Raise
- Jobs You Can Get with a Biology Degree
- Juul Receives FDA Clearance for Updated E-Cigarette With Age-Verification Technology
- Kailera’s Oral GLP-1 Drug Meets Primary Endpoints in Chinese Phase 3 Obesity and Diabetes Trials
- Kura Oncology Spins Out Lilly-Backed Biotech with $50M for Next-Gen Diabetes Therapy
- Kyverna Halts Development of Next-Generation CAR-T Therapy for Autoimmune Disease
- La Jolla Institute for Immunology
- Labcorp Launches Hepatitis D Reflex Test for Earlier Detection
- Legend Biotech and Its CAR T Therapy Carvykti
- Marine Biology Courses: What to Study and How to Choose
- Massachusetts Governor Makes Pre-Election Pitch to Biotech Firms as Early-Stage Startups Face Capital Crisis
- MeiraGTx Secures $400 Million from Oberland Capital to Advance Two Gene Therapies Toward Commercialization
- Menarini to Pay $72M Upfront, Up to $771M Total, for European Rights to Gan & Lee's GLP-1 Drug
- Merck Drops Sutro-Partnered IL-2 Drug in Pipeline Review
- Merck’s Efinopegdutide Shows Promise in Mid-Stage MASH Trial
- MetaVia’s GLP-1 Agonist Reduces Liver Fat and Body Weight in Phase 1 Trial; Phase 2 Planned for Alcohol-Associated Liver Disease
- Mirum Pharmaceuticals Meets Primary Endpoint in Second Phase 3 Trial for Hepatitis D Antibody
- Modern Research Peptides in Precision Medicine
- Moderna and Merck Report Positive Phase 3 Results for mRNA Cancer Vaccine
- Moderna and Merck Report Success for Cancer Vaccine
- Moderna Halts Norovirus Vaccine Trial Enrollment After Phase 3 Setback
- Moleculin Biotech
- Mutations Biology
- National Human Genome Research Institute: Leading the Genomic Revolution
- nChroma Bio Cuts Workforce in Half, Ends Hepatitis B Trial
- Neumora Therapeutics Appoints Joshua Pinto as CEO
- Neuroscience Research: Mapping the Brain
- NICE Recommends Two Diagnostics to Detect Endometriosis in England
- Novartis Cardiovascular Drug Pelacarsen Fails Key Trial
- Novartis Drug Reduces Inflammation; Heart Benefits Still Unproven
- Novartis Lp(a) Drug Fails to Reduce Cardiovascular Risk in Phase 3 Trial
- Novartis Lp(a) Drug Fails to Show Any Benefit in Cardiovascular Outcomes Trial
- Novartis Shareholder Demands Board Overhaul After Costly Clinical Failures
- Novartis Strikes $3.2 Billion Deal with Alteogen for Subcutaneous Drug Delivery
- Novo Nordisk Halts More Phase 3 Ziltivekimab Trials
- Novo Nordisk Halts Two Cardiovascular Trials for Inflammation-Targeting Drug
- Novo Nordisk Partners with Vivani Medical on Long-Acting GLP-1 Implant Technology
- Nucleic Acids Research: Techniques and Therapeutics
- Onchilles Reports Promising Results for Injectable Solid Tumor Treatment
- Panelists Debate Europe’s Biotech Funding Prospects for 2027 at London Event
- PepGen Stock More Than Doubles After Positive Midphase Data for Myotonic Dystrophy Type 1
- Pfizer Enters in Vivo CAR-T Field with $2.6 Billion Deal for Starna Therapeutics Programs
- Pfizer Sells Discontinued Seagen Antibody Drug Conjugate to Medicus Pharma
- Pharma and Biotech Industry Sees Latest Wave of Executive Moves
- Pharmaceutical Research
- Pheast Therapeutics CEO Stands by Transparent R&D Approach Despite Competitor Interest
- Protein-Protein Interaction Research May Reveal New Drug Targets for Autism
- Qiagen Appoints Jonathan M. Pratt as Chief Executive
- Remote Bioinformatics Jobs
- Remote Biology Jobs
- Researchers Use 10-Protein Blood Panel to Improve ALS Detection
- Revolution Medicines Wins RAS Inhibitor Approval, but a Wider Pipeline Is Taking Shape
- Rezera Files for $181 Million IPO to Fund Phase 3 Trial of NLRP3 Inhibitor
- Rezolute Shares Rise on Positive Phase 3 Trial for Tumor Hyperinsulinism Drug
- RN Programs
- Roche Signs $2.5B Deal for Hanmi’s Clinical-Stage Obesity Drug
- San Diego Biotech: Key Players and Growth Trends
- Sanofi-Backed Windward Bio Hits $225M IPO Target; Rezera Delays Listing
- Scribe Therapeutics Files for IPO to Fund Lipid-Lowering Genetic Medicines
- SEC and FDA Sign Three-Year Information-Sharing Agreement to Curb Insider Trading
- Sellas Leukemia Vaccine Shows 9-Month Survival Benefit in Phase 3 Trial
- Siemens Healthineers Spins Off In Vitro Diagnostics Unit as Olyrian Diagnostics
- SK Biopharmaceuticals Pays $350M Upfront to Accelerate Biohaven’s Epilepsy Drug Toward 2029 Launch
- Sonography Programs in Texas
- Southern Biotech
- Spyre Completes Trio of Phase 2 Wins in Inflammatory Bowel Disease with IL-23 Antibody
- Spyre Therapeutics Deprioritizes Rheumatoid Arthritis Development After Weak Phase 2 TL1A Data
- STAT Readers Weigh In on M.D. vs. D.O., AI in Medicine, and Surrogacy
- Stem Cell Research: iPSCs, Trials, and Ethics
- Systems Biology
- Teva Agrees to Acquire Bankrupt BioXcel’s Neuroscience Assets as Stalking Horse Bidder
- The Central Dogma of Molecular Biology
- The NC Biotech Center and Its Impact
- Tissue Biology Definition
- Tissue Definition in Biology: 4 Main Types, Structure & Functions
- Tissue Meaning Biology
- Tissues Definition Biology
- Top Biotech Companies in Drug Development
- Top Boston Hospitals Clash as Mass General Brigham Medicare Advantage Plan Drops Dana-Farber
- Transfer RNA as a Therapeutic for Genetic Diseases
- Translational Research
- Tyra Biosciences Advances Bladder Cancer Study as Midphase Results Disappoint Investors
- Ultragenyx Phase 3 Trial for Angelman Syndrome Fails; Company Plans Cost Cuts
- Vacant Lab Space, Shrinking Workforce Put Massachusetts in ‘Unique Position’ for Biotech Rebound, New Report Says
- Vertex Renews Genomics Discovery Pact in Deal Worth Up to $220 Million
- Veterinary Science
- Vivace Therapeutics Appoints Craig Gibbs as President and CEO
- Vor Bio Pays RemeGen $10 Million for Long-Acting Autoimmune Drug Candidate
- Werewolf Therapeutics to Merge with Ambros in Reverse Deal, Raising $150 Million for Rare Disease Drug
- What a Health Science Degree Can Do for Your Career
- What an Institute of Endocrinology Does
- what biotech
- What Can I Do With a Biology Degree?
- What Defines a Modern Biotech Company
- What Is Computational Biology
- What Is Human Biology? Cells, Systems, and Health
- What Is the Institute of Functional Medicine?
- What Jobs Can You Get With a Biology Degree?
- What Molecular Biology Really Means
- What the ASU Biodesign Institute Is Working On
- What the Panama Stem Cell Institute Offers Patients
- Where Neuroscience Jobs Are Found Today